BioNTech SE (BNTX) call put ratio 1 calls to 3.6 puts with a focus on March puts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
BioNTech (BNTX) PT Lowered to $151 at Truist Securities
March 11, 2025 11:46 AM EDTTruist Securities analyst Asthika Goonewardene lowered the price target on BioNTech (NASDAQ: BNTX) to $151.00 (from $172.00) while maintaining a Buy rating.
The analyst comments "BNTX's reported 4Q24 revenues of 1.19B was ~6% above consensus, but a bigger focus was the FY25 guidance, most notably the significantly... More
Jefferies Reiterates Buy Rating on BioNTech (BNTX)
March 10, 2025 2:23 PM EDTJefferies analyst Akash Tewari reiterated a Buy rating and $149.00 price target on BioNTech (NASDAQ: BNTX).
The analyst comments "Bottom line: BTNX reported an ok Q - Q4 revs ~1.19B vs 1.18B cons & EPS 1.08 vs 0.77 cons driven by lower Opex. That said, BNTX traded down... More



